Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 85-91) DOI: 10.5152/eurjrheum.2018.17113
(Eur J Rheumatol 2018; 5: 85-91) DOI: 10.5152/eurjrheum.2018.17113
(Eur J Rheumatol 2021; 8: 62-66) DOI: 10.5152/eurjrheum.2020.20193